Mistura says Homs terror attacks attempt to derail Geneva talksWorld February 26, 5:49
Annular eclipse will be visible in South America, Africa on Feb 26Science & Space February 26, 3:24
HNC expects Trump to correct Obama's mistakes in Syria - delegation headWorld February 26, 3:08
War on terror to dominate Geneva talks — Syrian UN envoyWorld February 25, 23:48
Russian skier wins gold in skiathlon at 2017 FIS Nordic World Ski ChampionshipsSport February 25, 17:46
Top US Air Force general points to growing conflict potential in Syrian airspaceWorld February 25, 17:17
Iran relies on Russia’s support in production of fuel for nuclear power plantsBusiness & Economy February 25, 16:20
Ukrainian military capture Donetsk water purification plant — spokesmanWorld February 25, 15:05
Azerbaijan and Armenia report armed clashes in Karabakh conflict areaWorld February 25, 11:45
MOSCOW, June 3. /TASS/. India’s Glenmark Pharmaceuticals Ltd is exploring an opportunity of localizing ready pharmaceutical drugs production in Russia, general director of Glenmark’s division in Russia Glenmark Impex Elena Astakhova said.
"We have such ideas and we are considering such an opportunity in principle. However, no final decision has been made yet," Astakhova said. She did not clarify the timeline and basic parameters of projects.
The company has no local production in Russia for the time being. The annual turnover of Glenmark in Russia is estimated at 2 bln rubles ($37.5 mln). Glenmark owns 14 ready drugs and substances factories in four countries and six research centers.